-- HighTide Therapeutics (HKG:2511) agreed to lend up to HK$15 million to its CEO Liu Liping, it said in a Monday Hong Kong bourse filing.
The pharmaceutical company's shares fell 1% in early afternoon trade Tuesday.
Borrowings under the facility are payable a year from drawdown and will accrue interest at 3.50% per annum.
Asia-Potash International Investment's (Guangzhou) (SHE:000893) net profit attributable to shareholders in the first quarter rose 39% year on year to 532.5 million yuan, or 0.58 yuan per share, according to a Shenzhen bourse filing on Tuesday.The attributable profit a year earlier was 384.4 million yuan, or 0.42 yuan per share.Operating revenue climbed 23% to 1.49 billion yuan from 1.21 billion yuan in the previous year.
Sichuan Huafeng Technology's (SHA:688629) net profit attributable to shareholders in the first quarter surged 230% to 105 million yuan from 31.8 million yuan a year earlier, according to a Shanghai bourse filing on Tuesday.Earnings per share soared 229% year on year to 0.23 yuan from 0.07 yuan.Operating revenue jumped 56% to 633 million yuan from 405.5 million yuan in the prior year.The electrical connectors manufacturer's shares slumped less than 6% during the afternoon trade.
HUB24 (ASX:HUB) said the Commonwealth Bank of Australia (ASX:CBA) and its related entities became a substantial holder in the company on April 24 with a stake of 5.02% or 4.1 million shares, according to a Tuesday Australian bourse filing.